6.274

0.88% -0.056

Puma Biotechnology Inc (PBYI)

Overview News Price History Option Chain Financials Discussions Forecast

Puma Biotechnology Inc stock is traded at $6.274, with a volume of 66,159. It is down -0.88% in the last 24 hours and down -17.45% over the past month. Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

Previous Close:

$6.33

Open:

$6.21

24h Volume:

66,159

Relative Volume:

0.16

Market Cap:

$319.25M

Revenue:

$228.37M

Net Income/Loss:

$31.11M

P/E Ratio:

10.27

EPS:

0.6108

Net Cash Flow:

$41.73M

1W Performance:

+2.02%

1M Performance:

-17.45%

6M Performance:

+29.63%

1Y Performance:

+100.45%

1-Day Range:

$6.20

$6.45

1-Week Range:

$6.07

$6.52

52-Week Range:

$2.575

$7.68

Puma Biotechnology Inc Stock (PBYI) Company Profile

Name

Puma Biotechnology Inc

Sector

Healthcare (1117)

Industry

Biotechnology (623)

Phone

(424) 248-6500

Address

10880 WILSHIRE BLVD., LOS ANGELES, CA

Employee

179

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

PBYI's Discussions on Twitter

Compare PBYI vs VRTX, REGN, ALNY, ARGX, INSM

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PBYI Puma Biotechnology Inc	6.275	322.05M	228.37M	31.11M	41.73M	0.6108
VRTX Vertex Pharmaceuticals Inc	455.16	115.58B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	759.97	79.23B	14.34B	4.50B	3.77B	41.56
ALNY Alnylam Pharmaceuticals Inc	331.35	43.59B	3.71B	313.75M	465.38M	2.2571
ARGX Argen X Se Adr	695.80	43.26B	4.16B	1.29B	734.26M	19.58
INSM Insmed Inc	149.44	31.97B	606.42M	-1.28B	-997.58M	-6.403

Puma Biotechnology Inc Stock (PBYI) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-28-21	Upgrade	Citigroup	Neutral → Buy
Jun-25-20	Resumed	BofA/Merrill	Underperform
Oct-08-19	Downgrade	Goldman	Neutral → Sell
May-10-19	Downgrade	Cantor Fitzgerald	Overweight → Neutral
May-10-19	Downgrade	Citigroup	Buy → Neutral
Jan-17-19	Initiated	Leerink Partners	Mkt Perform
Jan-03-19	Downgrade	Guggenheim	Buy → Neutral
Nov-19-18	Upgrade	Goldman	Sell → Neutral
Nov-02-18	Downgrade	BofA/Merrill	Buy → Underperform
Nov-02-18	Downgrade	JP Morgan	Neutral → Underweight
Oct-01-18	Initiated	Cantor Fitzgerald	Overweight
Sep-17-18	Initiated	Goldman	Sell
May-11-18	Reiterated	Stifel	Buy
Nov-10-17	Reiterated	Citigroup	Buy
Nov-10-17	Reiterated	RBC Capital Mkts	Sector Perform
Oct-02-17	Reiterated	Stifel	Buy
Sep-11-17	Reiterated	Credit Suisse	Outperform
Jul-10-17	Resumed	Leerink Partners	Outperform
Jun-06-17	Reiterated	RBC Capital Mkts	Sector Perform
May-25-17	Reiterated	RBC Capital Mkts	Sector Perform
Mar-02-17	Reiterated	RBC Capital Mkts	Sector Perform

View All

Puma Biotechnology Inc Stock (PBYI) Latest News

Mar 25, 2026

Forecast Cut: Is Puma Biotechnology Inc a momentum stockPortfolio Update Report & Risk Managed Trade Strategies - baoquankhu1.vn

Mar 25, 2026

Rate Hike: Can Puma Biotechnology Inc be the next market leaderPortfolio Update Summary & AI Powered Buy and Sell Recommendations - baoquankhu1.vn

Mar 25, 2026

Mar 24, 2026

Puma Biotechnology stock declines more than 9% in a month: Here's why - MSN

Mar 24, 2026

Mar 23, 2026

PBYI SEC FilingsPuma Biotechnology Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 23, 2026

Mar 21, 2026

Wall Street Zen Upgrades Puma Biotechnology (NASDAQ:PBYI) to Strong-Buy - MarketBeat

Mar 21, 2026

Mar 19, 2026

Shorts Report: Is Puma Biotechnology Inc undervalued by DCF analysis2026 Trading Volume Trends & Reliable Price Breakout Signals - baoquankhu1.vn

Mar 19, 2026

Mar 18, 2026

Whats the MACD signal for Puma Biotechnology Inc2026 Market WrapUp & Weekly Setup with ROI Potential - baoquankhu1.vn

Mar 18, 2026

Earnings Miss: Can Puma Biotechnology Inc be the next market leaderQuarterly Trade Summary & Expert Verified Movement Alerts - baoquankhu1.vn

Mar 18, 2026

Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why - Yahoo Finance

Mar 18, 2026

Buy Signal: Is Puma Biotechnology Inc trading at a discount2026 Sector Review & Breakout Confirmation Alerts - baoquankhu1.vn

Mar 18, 2026

Mar 17, 2026

Puma Biotechnology Stock Crosses 200-Day Moving Average - National Today

Mar 17, 2026

Puma Biotechnology (NASDAQ:PBYI) Share Price Passes Above Two Hundred Day Moving AverageHere's Why - MarketBeat

Mar 17, 2026

Mar 12, 2026